Research interests
Branched-chain amino acids and cardiometabolic disease[9]
Robert W. McGarrah
Associate Professor of Medicine
Current relationship
Associate Professor of Medicine
Current relationship
Bending the Cardiovascular Event Curve by Evaluating the Potential Impact of Achieving Low-Density Lipoprotein Cholesterol Goal Across a Large Health System Among Secondary Prevention Patients
Branched-chain amino acids in cardiovascular disease
Design and Rationale of the pERSonalized cardIovascuLar dIsease prEvention, treatmeNt, and CarE (RESILIENCE) study
Lipid-Lowering Therapy in Women of Childbearing Age: a Review and Stepwise Clinical Approach
Lipoprotein Subclasses Associated With High-Risk Coronary Atherosclerotic Plaque: Insights From the PROMISE Clinical Trial
Metabolic Effects of the SGLT2 Inhibitor Dapagliflozin in Heart Failure Across the Spectrum of Ejection Fraction
Mitochondrial metabolites predict adverse cardiovascular events in individuals with diabetes
Multimarkers of metabolic malnutrition and inflammation and their association with mortality risk in cardiac catheterisation patients: a prospective, longitudinal, observational, cohort study
Risk factors for cardiovascular disease among individuals with hepatic steatosis
Robert W. McGarrah is a Duke cardiology faculty member whose work links heart disease prevention and rehabilitation with cardiometabolic disease. He is an Associate Professor of Medicine and a member of the Duke Molecular Physiology Institute. His training includes an M.D. from the University of North Carolina (2008), internal medicine residency and cardiovascular research fellowship at Massachusetts General Hospital (2008–2012), and cardiovascular disease fellowship at Duke (2012–2016). His research interests include branched-chain amino acids and cardiometabolic disease, with publications addressing lipoprotein subclasses, mitochondrial metabolites, heart failure, hepatic steatosis, and personalized cardiovascular prevention. His record includes a 2023 review on branched-chain amino acids in cardiovascular disease and the 2026 RESILIENCE study design paper.
Serum Metabolites Are Associated With HFpEF in Biopsy-Proven Nonalcoholic Fatty Liver Disease
Each topic is linked to its supporting source in Sources.
MGH Internal Medicine at MGH (previously observed).
Training includes Cardiovascular Disease Fellowship at Duke University, School of Medicine, Research Fellow, Cardiovascular Research Center at Massachusetts General Hospital, Internal Medicine Residency at Massachusetts General Hospital, and MD, plus 2 more records.
Explore education and trainingAs of 2023
As of 2016
As of 2012
As of 2011
Completed 2008
Branched-chain amino acids and cardiometabolic disease[9]